FDA Recalls Brilliant Blue G After Eye Infection Reports
The U.S. Food and Drug Administration announced a recall of the drug Brilliant Blue G on Monday, after receiving reports of eye infections in patients who were given it during eye...To view the full article, register now.
Already a subscriber? Click here to view full article